Back to results
US 2012/0269891 A1Published application
Controlled release oral pharmaceutical dosage forms comprising mgbg
AssigneePathologica LLC
InventorsJohn McKearn, Jeremy Blitzer
Life of this patent
Estimating the term…
Abstract
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
Claims30
A controlled-release oral pharmaceutical dosage form comprising MGBG.
A delayed-release oral pharmaceutical dosage form comprising MGBG dihydrochloride hydrate in capsule enterically-coated for duodenal release.
A method of treating pain comprising the administration, to a patient in need thereof, a delayed-release oral pharmaceutical dosage form comprising MGBG.
Dependencies are inferred from the claim text.